BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24410803)

  • 1. A prostate biopsy strategy based on a new clinical nomogram reduces the number of biopsy cores required in high-risk patients.
    Huang Y; Cheng G; Liu B; Shao P; Qin C; Li J; Hua L; Yin C
    BMC Urol; 2014 Jan; 14():8. PubMed ID: 24410803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a model for forecasting Gleason score ≥7 in potential prostate cancer patients to reduce unnecessary prostate biopsies.
    Li X; Pan Y; Huang Y; Wang J; Zhang C; Wu J; Cheng G; Qin C; Hua L; Wang Z
    Int Urol Nephrol; 2016 Apr; 48(4):535-40. PubMed ID: 26810323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The optimal number of initial prostate biopsy cores in daily practice: a prospective study using the Nara Urological Research and Treatment Group nomogram.
    Tanaka N; Shimada K; Nakagawa Y; Hirao S; Watanabe S; Miyake M; Anai S; Hirayama A; Konishi N; Fujimoto K
    BMC Res Notes; 2015 Nov; 8():689. PubMed ID: 26581414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the risk of harboring prostate cancer by a prebiopsy nomogram based on extended biopsy protocol.
    Nicolaiew N; Ploussard G; Chun FK; Xylinas E; Allory Y; Salomon L; de la Taille A
    Urol Int; 2013; 90(3):306-11. PubMed ID: 23295308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore.
    Lee A; Lim J; Gao X; Liu L; Chia SJ
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e348-e355. PubMed ID: 27641069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a follow-up strategy for patients with PSA ranging from 4 to 10 ng/ml via a new model to reduce unnecessary prostate biopsies.
    Zhao R; Huang Y; Cheng G; Liu J; Shao P; Qin C; Hua L; Yin C
    PLoS One; 2014; 9(9):e106933. PubMed ID: 25268808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone.
    Niu XK; Li J; Das SK; Xiong Y; Yang CB; Peng T
    BMC Med Imaging; 2017 Feb; 17(1):11. PubMed ID: 28143433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer.
    Tang P; Chen H; Uhlman M; Lin YR; Deng XR; Wang B; Yang WJ; Xie KJ
    Asian J Androl; 2013 Jan; 15(1):129-33. PubMed ID: 23291910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
    Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
    Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy.
    Nowroozi MR; Amini S; Kasaeian A; Zavarehei MJ; Eshraghian MR; Ayati M
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e289-97. PubMed ID: 24684767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing a Correct System to Evaluate the Accuracy of Gleason Score in Prostate Cancer of Chinese Population.
    Wang J; Cheng G; Li X; Huang Y; Pan Y; Qin C; Hua L; Wang Z
    Urol Int; 2016; 96(3):295-301. PubMed ID: 26849662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of a Chinese nomogram based on muti-parametric magnetic resonance for predicting the probability of prostate cancer in patients after initial negative biopsy].
    Huang C; Ji GJ; Song G; Wang H; Chen YK; Zhou LQ
    Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(2):132-135. PubMed ID: 29343039
    [No Abstract]   [Full Text] [Related]  

  • 13. Chinese nomogram to predict probability of positive initial prostate biopsy: a study in Taiwan region.
    Kuo SC; Hung SH; Wang HY; Chien CC; Lu CL; Lin HJ; Guo HR; Zou JF; Lin CS; Huang CC
    Asian J Androl; 2013 Nov; 15(6):780-4. PubMed ID: 24121978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
    Nakanishi H; Wang X; Ochiai A; Trpkov K; Yilmaz A; Donnelly JB; Davis JW; Troncoso P; Babaian RJ
    Cancer; 2007 Dec; 110(11):2441-7. PubMed ID: 17932909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients.
    Suzuki H; Komiya A; Kamiya N; Imamoto T; Kawamura K; Miura J; Suzuki N; Nakatsu H; Hata A; Ichikawa T
    Urology; 2006 Jan; 67(1):131-6. PubMed ID: 16413348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.
    Kawamura K; Suzuki H; Kamiya N; Imamoto T; Yano M; Miura J; Shimbo M; Suzuki N; Nakatsu H; Ichikawa T
    Int J Urol; 2008 Jul; 15(7):598-603. PubMed ID: 18462353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment of a nomogram for predicting positive repeat prostate biopsy in Chinese men].
    Li QY; Tang J; Li YM; Fei X; Zhang Y; He EH; Zhou Y
    Zhonghua Nan Ke Xue; 2012 Apr; 18(4):302-5. PubMed ID: 22574362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of two on-line risk calculators versus the detection of circulating prostate cells for the detection of high risk prostate cancer at first biopsy.].
    Murray NP; Fuentealba C; Reyes E; Jacob O
    Arch Esp Urol; 2017 Jun; 70(5):503-512. PubMed ID: 28613202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mL.
    Garzotto M; Hudson RG; Peters L; Hsieh YC; Barrera E; Mori M; Beer TM; Klein T
    Cancer; 2003 Oct; 98(7):1417-22. PubMed ID: 14508828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outcomes of transrectal ultrasound guided biopsy of the prostate in a New Zealand population.
    Lienert AR; Davidson PJ; Wells JE
    N Z Med J; 2009 Jan; 122(1288):39-49. PubMed ID: 19182841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.